Eli Lilly Given Green Light for Long-lasting Zyprexa


The US Food and Drug Administration (FDA) has approved a long-lasting injectable version of Eli Lilly’s antipsychotic blockbuster Zyprexa.

Zyprexa Relprevv was found to be effective in controlling systems of schizophrenia, including hallucinations, delusions, apathy and social withdrawal.

Schizophrenia patients currently take the the Zyprexa pill daily, but the new formulation will allow patients to visit their doctors only every two to four weeks to receive their injection. It is hoped that this longer-lasting version will make it easier for patients to remain on the medication and for doctors to track that they are doing so.

CK Science is proud to provide unrivalled scientific recruitment services to world-class clients such as Eli Lilly. To seach for your next science job, please click here.

CKScience    linkedin   twitter    facebook    youtube

Posted in: General, News
CK Logo in place of featured image